Chemoinformaics analysis of 4(15)-Dehydroglobulol
Molecular Weight | 220.356 | nRot | 0 |
Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
Exact Molecular Weight | 220.183 | nRing | 3 |
Solubility: LogS | -3.777 | nHRing | 0 |
Solubility: LogP | 4.208 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.62 |
Synth | 4.39 |
Natural Product Likeliness | 3.147 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.481 |
MDCK | 0.0000227 |
BBB | 0.949 |
PPB | 0.642734 |
VDSS | 1.124 |
FU | 0.340058 |
CYP1A2-inh | 0.223 |
CYP1A2-sub | 0.45 |
CYP2c19-inh | 0.096 |
CYP2c19-sub | 0.881 |
CYP2c9-inh | 0.112 |
CYP2c9-sub | 0.17 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.512 |
CYP3a4-inh | 0.113 |
CYP3a4-sub | 0.461 |
CL | 15.633 |
T12 | 0.076 |
hERG | 0.038 |
Ames | 0.006 |
ROA | 0.797 |
SkinSen | 0.165 |
Carcinogencity | 0.499 |
EI | 0.115 |
Respiratory | 0.974 |
NR-Aromatase | 0.006 |
Antiviral | Yes |
Prediction | 0.880431 |